Knowing that a threat is emerging is a critical element in response and recovery planning. If the threat has been well anticipated, the information about speed, location, target communities, and the population at risk become critical information. Knowing what is…
September is Preparedness Month and this is the first of four blogs we will post during this month focusing on various aspects of preparedness. In this missive, I will talk about threats since preparedness is first and foremost about anticipation…
As I am writing this on August 30, 2021, we are seeing the devastation wrought by Hurricane Ida. It is also the day 16 years ago that the people of New Orleans realized that in fact, they had not dodged…
Will Alternative Care Sites (ACS) be necessary? Watching the epidemiologic data recording the rise of COVID cases caused by the delta variant is quite worrisome, and modelers are predicting significant new cases, hospitalizations, and deaths. The stresses and pressures of…
The US is making progress in getting control of this global pandemic that has affected our lives significantly. COVID-19 cases are still high, but hospitalizations and deaths are declining. Our experience shows that we still need to pursue the activities…
This is a very fraught question but one of importance. This blog will not answer the question, but make some observations about what has changed already. The wider question of how health delivery will function with changes wrought by the…
Let’s Prevent Hospitalizations and Consider Monoclonal Antibody Treatments In November, 2020, FDA issued Emergency Use Authorizations (EUA) for two monoclonal antibody products. An EUA is different than full FDA approval in that it is issued in emergent circumstances, usually without…
Today is just a short reflection on the efforts to vaccinate 330 M people. Thanks to discovery scientists exploring new means to initiate immune response to viruses, we saw a remarkably fast advanced development and manufacture of vaccines with >…
As the SARS-CoV2 virus has surged across the US in the last month, EWP has seen increasing pressure on hospitals who are hard pressed to accommodate patients due to limitations in staff, space, and equipment. Although many facilities have invoked…
We have seen this week a second vaccine developer approach the FDA for Emergency Use Authorization (EUA) of a new vaccine for SARS-CoV2. The race to the starting line has a couple winners, although we expect that more vaccine candidates…